S-adenosyl-l-homocysteine hydrolase from Pseudomonas aeruginosa (PaSAHase) coordinates one K+ ion and one Zn2+ ion in the substrate binding area. The cations affect the enzymatic activity and substrate binding but the molecular mechanisms of their action are unknown. Enzymatic and isothermal titration calorimetry studies demonstrated that the K+ ions stimulate the highest activity and strongest ligand binding in comparison to other alkali cations, while the Zn2+ ions inhibit the enzyme activity. PaSAHase was crystallized in the presence of adenine nucleosides and K+ or Rb+ ions. The crystal structures show that the alkali ion is coordinated in close proximity of the purine ring and a 23Na NMR study showed that the monovalent cation coordination site is formed upon ligand binding. The cation, bound in the area of a molecular hinge, orders and accurately positions the amide group of Q65 residue to allow its interaction with the ligand. Moreover, binding of potassium is required to enable unique dynamic properties of the enzyme that ensure its maximum catalytic activity. The Zn2+ ion is bound in the area of a molecular gate that regulates access to the active site. Zn2+ coordination switches the gate to a shut state and arrests the enzyme in its closed, inactive conformation.
S-adenosyl-l-methionine (SAM) is a ubiquitous methyl group donor in methylation reactions of a wide range of acceptors including small and macromolecules1. The SAM-dependent reactions generate equimolar amounts of S-adenosyl-l-homocysteine (SAH), which is a strong inhibitor of SAM-dependent methyltransferases and needs to be removed to keep the metabolic processes going. By hydrolyzing SAH to adenosine (Ado) and L-homocysteine (Hcy), the enzyme SAHase (SAH hydrolase) serves as an important regulator of SAM-dependent methylation through the control of the SAM:SAH ratio, and is an indicator of the biological methylation activity of the cell2,3,4. SAHase inhibition or dysfunction leads to the accumulation of SAH in the cell and arrest of all crucial SAM-dependent processes. Apart from SAH hydrolysis, which is catalyzed in both directions, the enzyme also splits 2′-deoxyadenosine, which is an irreversible inhibitor of SAHases5. SAHase inactivation by 2′-deoxyadenosine proceeds via the formation of an unstable 3′-keto-2′-deoxyadenosine in an NAD+-dependent process that is very similar to the first step of the main SAH breakdown reaction. The subsequent and spontaneous cleavage of the N-glycosidic bond leads to the elimination of a modified sugar moiety, while the adenine molecule stays bound in the active site of the enzyme6. The reduced cofactor (NADH) is not regenerated in the 2-deoxyadenosine reaction, stalling the enzyme in the inactive form.
SAHases are usually active as homotetramers7,8,9,10,11,12,13,14,15. The protomer has a three-domain fold, with two prominent domains, the substrate- and cofactor-binding domains, separated by a deep crevice. A small C-terminal dimerization domain locks two subunits into a homodimer by quaternary complementation of the cofactor binding site, where a tightly but non-covalently bound nicotinamide adenine dinucleotide (NAD+) is found in its oxidized form. During the catalytic SAHase cycle, the cofactor is first reduced upon abstraction of a hydride anion from the C3′ atom of the sugar moiety. To complete the cycle, the NAD+ cofactor is regenerated through Michael-type addition of a water molecule16. The latter step is not part of the irreversible inactivation of the enzyme by 2′-deoxyadenosine, in which case the cofactor is trapped in its non-reactive, reduced state5,6. The enzyme undergoes a significant open-closed conformational transformation upon substrate or inhibitor binding. A comparison of the enzyme conformation in the open and in the closed forms reveals that the interdomain crevice is constricted upon substrate or inhibitor binding. The accessibility of the active site from the solvent region is regulated by a molecular gate formed by a conserved pair of His-Phe residues6,10,11. Depending on the conformational state of the gate, the channel leading to the active site can be open or shut. The structures of SAHases from various species were determined mainly for the enzymes in the closed conformation, in the presence of adenosine (Ado) or its analogs. In most of those structures, various monovalent cations were found in a coordinating loop located in close proximity of the substrate binding site. However, the ions do not interact with the ligand directly. The type of the coordinated ion strongly depends on the crystallization conditions, which included NH4+, Na+ or K+ cations. Only a few SAHase structures correspond to the open form8,11, which is correlated with the absence of an active-site ligand, as well as of a monovalent cation in the substrate binding region. This suggests that the cation is coordinated upon a conformational transformation of the enzyme during the catalytic cycle. However, it is still unclear which monovalent cation is utilized by the enzyme under physiological conditions and what role it serves in the catalytic process. Additionally, it has been suggested that SAHase activity could be regulated by some divalent cations, e.g., copper17. However, so far none of the previously determined SAHase structures contained any metal cations other the monovalent ones6,7,9,10,11,14,15,18,19.
Pseudomonas aeruginosa has natural resistance to many antibiotics and disinfectants and is responsible for numerous infections. Therefore, defining new molecular targets for the treatment of P. aeruginosa infections is of high medical priority. The purpose of the present study has been to define the catalytic role of the monovalent cations and to explain the molecular mechanism of P. aeruginosa SAHase (PaSAHase) inhibition by zinc ions. By combining X-ray crystallography with enzyme kinetics and ITC studies, as well as with 23Na NMR spectroscopy, we were able to elucidate the effect of the monovalent cations on ligand binding, and to explain that the enzyme is most efficient in the presence of potassium. Also, we confirmed the presence of zinc ions by X-ray fluorescence and explained how Zn2+ binding blocks a molecular gate, leading to a complete inhibition of enzymatic activity.
Overall structure of PaSAHase
We present four crystal structures of PaSAHase/ligand/ion(s) complexes at resolutions of 1.35 to 1.75 Å (Supplementary Information Table S1). Two complexes of Zn2+-containing PaSAHase were crystallized in the presence of K+ ions and adenosine (Ado/K+/Zn2+), or an inhibitor, 2′-deoxyadenosine (2′-dAdo/K+Zn2+). Additionally, the latter ligand as well as 3′-deoxyadenosine (non-metabolized adenosine analog) were used for crystallization of zinc-free enzyme in the presence of Rb+ (2′-dAdo/Rb+) or K+ (3′-dAdo/K+) cations. In the Zn2+-containing complexes, the divalent cation site is not fully occupied. Despite the very low activity of the enzyme in the presence of Zn2+ cations, 2′-deoxyadenosine undergoes catalytic cleavage at the N-glycosidic bond during incubation with the enzyme or during crystallization6. Therefore, only adenine is found in the active site of PaSAHase crystallized in the presence of 2′-deoxyadenosine and K+ or Rb+ cations. It is of note, that the absence of sugar moiety does not change the spatial arrangement of the active site when compared to the complexes with nucleosides. This results from the presence of a phosphate anion from a crystallization buffer, which mimics the positions of the oxygen atoms of the ribose moiety. A similar effect was noted previously6,19, when four water molecules, superposable with the oxygen atoms of the sugar moiety, were observed close to the adenine molecule. The four water molecules, as well as the phosphate anion are involved in a hydrogen bond network that is very similar to that observed in nucleoside complexes. The presence of water molecules or a phosphate ion depends only on the crystallization conditions. Thus, the anion is not required for adenine binding and to stabilize the closed conformation of the protein. Moreover, the molecule that binds directly to the enzyme is 2′-deoxyadenosine, which is then slowly decomposed to adenine and a sugar moiety5. It should be noted that SAHase enzymatic activity assays are carried out in phosphate buffer, as this anion has no inhibitory effect on SAHase activity20,21,22.
The binding modes of adenine and its nucleosides in the active site of PaSAHase are similar to those observed in other SAHase models of various origin6,7,9,10,11,14,15,18,19,23,24, as shown in Fig. 1a–d. The polar interactions in the active site of the enzyme in all four complexes are presented in Supplementary Information (Table S2). It is of note that in the presented PaSAHase complexes, adenine or its nucleosides are trapped in the active site, as the H323-F324 molecular gate is shut (Fig. 1e).
PaSAHase forms a homotetramer in solution. The complexes crystallize in two different forms, either as a tetramer or as a dimer from which the complete homotetramer is generated by crystallographic symmetry. All the tetramers are very similar, with r.m.s. deviations of their Cα superpositions ranging from 0.08–0.35 Å. A multiple sequence alignment of amino acid sequences of different SAHases (Fig. 2a) reveals a lineage-specific insertion segments in PaSAHase, located in the substrate (inserted residues 414–419) and cofactor (inserted residues 270–280 and 353–359) binding domains on the surface of the enzyme (Fig. 2b,c).
The monovalent cation near the active site of PaSAHase
In all presented PaSAHase complexes, the four subunits exist in the closed conformation and each of them binds an adenine nucleoside or adenine, as well as an alkali metal cation, K+ or Rb+, in the substrate binding area (Fig. 3a). The K+/Rb+ cations are bound in the monovalent cation coordinating loop (T380-S384) in close proximity of the purine ring of the ligand, but they do not interact with the ligand directly. Additionally, using anomalous dispersion, one non-specific Rb+ site per PaSAHase tetramer was found as a crystallization artifact in the rubidium complex. The metal coordination loop is part of one of the two hinge regions linking the substrate- and cofactor-domains that are involved in substrate-induced domain movements8,23,24. The coordination sphere of the K+/Rb+ cations is a slightly distorted pentagonal bipyramid (Supplementary Information Table S3) formed by two main-chain carbonyl oxygen atoms (T380 and H382) and the side-chain oxygen atoms of T380 and a highly conserved Q65 residue involved in ligand binding. Three water molecules complete the coordination sphere. A very similar coordination geometry of the K+ cation was observed in the crystal structure of SAHase from Brucella melitensis (PDB ID: 3N58, unpublished). Other SAHase models deposited in the PDB bind NH4+ or Na+ cations at this position. Moreover, in numerous PDB models this position is marked as a water molecule, while in fact it is an alkali metal cation, most likely Na+, coordinated by at least five oxygen atoms. Despite the presence of different monovalent cations, the conformation of the coordinating loop and of the Q65 residue is not affected to any significant degree; likewise, the position of the ligand molecule is very similar in all analyzed models (Fig. 3b). The presence of cations other than potassium is usually reflected in a different arrangement of the coordination sphere (Supplementary Information Table S4). Most importantly, the amide oxygen of the highly conserved Q65 residue interacts with NH4+ or Na+ ions indirectly, via a water molecule6,10,11, with one notable exception (PDB ID: 5M5K) where the glutamine side chain is involved in direct sodium coordination19.
Effect of monovalent cations on PaSAHase activity
The crystal structures of SAHases available so far contain NH4+, Na+ or K+ ions near the substrate binding site, depending on the composition of the purification and crystallization media. The obvious candidate for the monovalent cation involved in the enzymatic activity of SAHase under physiological conditions is potassium, which is the major cation of all living cells and is also a common metal cation bound to cellular proteins25. Within this project, enzyme kinetics and isothermal titration calorimetry (ITC) studies were conducted in the presence or absence of alkali cations to investigate their influence on the enzymatic activity and ligand binding of PaSAHase. (Tables 1, 2 and Fig. 4). In the kinetic experiments, the highest activity was observed in the presence of K+ cations. The catalytic rate (kcat) of the reaction in the presence of K+ is 0.575 ± 0.009 s−1 and is 2–11 times higher when compared to the rates measured in the presence of other alkali ions or without them. In the case of Rb+, the drop of kcat is almost 33-fold. Moreover, for most of the reactions, the substrate affinity (KM) is 3–12 times higher in the presence of potassium. The notable exception is the reaction in the presence of Rb+, where the measured substrate affinity is slightly higher than for potassium. Finally, the catalytic proficiency index kcat/Km is one to over two orders of magnitude higher in the presence of potassium than for other ions. These findings clearly demonstrate that the enzyme attains its maximum catalytic activity when the K+ cation is bound. On the other hand, Rb+ acts as noncompetitive inhibitor.
Also the ITC experiments indicate the importance of K+ cations for ligand (adenosine) binding. During the titrations conducted in the absence of any alkali metals or the presence of Li+ ions, the heat effect was immeasurably small. For the experiments conducted in the presence of Na+, K+, Rb+ and Cs+ ions, the stoichiometry of adenosine binding to the enzyme is one ligand molecule per subunit. The optimal cation for PaSAHase-Ado binding is K+, as the ligand binding is mostly enthalpy driven and the binding constant Kd of 1.2 ± 0.2 µM is the lowest in the presence of potassium. Adenosine binding is only slightly weaker in the presence of Rb+. However, the use of Na+ or Cs+ cations resulted in a significant decrease of binding specificity and increase of entropy contribution (Table 2).
Formation of the monovalent cation binding site
The majority of the crystallographic models of SAHases in the PDB present the enzyme in the closed conformation with a ligand and a monovalent cation bound in the substrate binding region. A few structures present a situation where one or all four subunits of the tetrameric enzyme do not bind a ligand and, therefore, adopt the open conformation8,11. In one case, a subunit does contain a ligand (3′-deoxyadenosine) but is found in a semi-open conformation, intermediate between the open and closed states19. Those models were derived from crystals that were grown in the presence of NH4+, Na+ or K+ cations. Inspection of the subunits that are in the open conformation reveals that there is no monovalent cation bound near the substrate binding site, although the metal coordination loop has the same conformation as in the subunits with the closed conformation (Fig. 3c). Also, a very similar loop conformation is observed for the subunit in the semi-open state, however, an undifferentiated water molecule/ammonium ion is located in the position of the monovalent cation. The major structural difference between the closed/semi-open and open states concerns the conformation of Q65 (PaSAHase numbering). In the open state this residue is located far away from the metal binding loop and its side chain is disordered in at least two conformations. Thus, the crystallographic models suggest that the coordination of the monovalent cation does not occur until a conformational transformation upon ligand binding in the active site has taken place. This postulate was confirmed by two other experiments. (i) No effect other than K+ dilution heat was observed during the isothermal titration of a ligand- and alkali-metal-free PaSAHase with K+ ions. This result suggests that the cation does not bind specifically to the enzyme in its open (i.e., ligand-free) conformation. (ii) In 23Na NMR spectra recorded for either adenosine or PaSAHase in the presence of 5 mM NaCl, only one peak is observed with a chemical shift as for NaCl itself (Supplementary Information Fig. S1a). This shows that, in general, the environment of the sodium nuclei is the same in all three samples. The NMR results are in agreement with the isothermal titration data and confirm that monovalent cations (at least Na+) do not bind specifically to the open form of the protein. The observed broadening of the 23Na resonance in the sample containing PaSAHase indicates that non-specific Na+-protein interactions cannot be excluded. The situation is changed when the spectra are recorded for samples containing both the enzyme and the adenosine ligand in the presence of Na+ ions. In this scenario, PaSAHase should adopt the closed conformation enforced by adenosine binding, allowing the cation to be coordinated near the ligand, as indicated by the crystallographic results. In agreement with this scenario, a small but meaningful shift is observed in the 23Na NMR spectrum of PaSAHase/adenosine/23Na+. This effect increases with a decrease of the Na+:PaSAHase ratio (Supplementary Information Fig. S1b) owing to the increased proportion of protein-coordinated Na+ ions in the sample and a concomitant contribution of the bound form to the position of the 23Na signal, which is the weighted average of two signals in fast exchange, derived from the nuclei of protein-coordinated and unbound/hydrated Na+ ions.
In view of all the above observations, the emerging course of events is that the K+ ion coordination site is formed only upon ligand binding, when the enzyme changes its conformation from the open to the closed state. This site is composed of the highly conserved Q65 residue as well as of the loop region T380-S384 that links the substrate- and cofactor-binding domains, with T380 and H382 involved in direct cation coordination. Interestingly, the conformation of the loop does not change significantly during this transformation (Fig. 3c). The situation at the Q65 residue is drastically different. In the open form of the enzyme, the Q65 residue is far from the loop region and its side chain is disordered. Upon ligand binding, Q65 moves close to the coordination loop as the result of the movement of the substrate-binding domain towards the cofactor-binding domain, so that its side chain can directly coordinate the potassium cation. In addition, metal coordination stabilizes and orders the side chain of Q65. With the Oε atom coordinated to the metal cation, the amide group of Q65 is now adequately oriented for the formation of an Oε…N hydrogen bond with the exoamino group of the adenine moiety of the ligand. The importance of Q65 in ligand binding and enzymatic activity of PaSAHase is reflected in our mutagenesis study. In the presence of K+ ions, the Q65A mutant is over four times less active and the KM value increases over three times compared to the wild type enzyme. The catalytic proficiency index kcat/Km is over one order of magnitude lower. ITC titrations also confirmed the importance of the Q65 residue for the catalytic cycle. During the titrations of the Q65A mutant with adenosine in the presence of K+, the stoichiometry of adenosine binding to the enzyme is ~0.25, indicating that, on average, three substrate binding sites of the tetramer remain empty. Finally, more than six-fold drop of adenosine affinity is observed in comparison to native PaSAHase. The kinetic and thermodynamic measurements are presented in Fig. 4 and in Tables 1 and 2.
The highly conserved glutamine residue and its rare substitutions
Phylogenetic analyses of SAHase sequences indicate that the enzymes diverged into two major groups during their evolution26. The first group comprises enzymes from bacterial and eukaryotic organisms while the second is formed by archaeal SAHases. The consequences of this divergent evolution are also visible at the structural level. In particular, the mode of adenine ring binding in the substrate domain is different in SAHases from different species. The Q65 residue is highly conserved among bacterial and eukaryotic sequences (Fig. 2a). Phylogenetic analyses suggest that the primordial residue that interacted with the adenine amine group was indeed glutamine. Among eukaryotic SAHases, only in mammalian (e.g., human) and some protozoan (e.g., the pathogenic strains of Plasmodium, Cryptosporidium, Theileria and Naegleria) enzymes this glutamine residue is substituted by glutamate. It is of note that these protozoan pathogens are obligate intracellular parasites of humans and other animals with the same substitution. This might suggest co-evolution (but not horizontal gene transfer, as these sequences belong to distant branches of the phylogenetic tree) of the host-pathogen pair with the further implication that the presence of glutamate instead of glutamine at this position is a relatively new evolutionary feature in the first group of SAHases. The crystal structures of several mammalian and protozoan SAHases that carry the Gln→Glu substitution were solved in the presence of Na+ or NH4+ cations9,14,27. With this substitution, the glutamate carboxylic oxygen can interact directly, or indirectly via a water molecule, with the Na+ cation, analogously to the amide oxygen of the glutamine side chain (Supplementary Information Table S4). However, the alkali metal cation is still required for the glutamate side chain ordering. Among SAHases from the second, archaeal group, this position can be occupied either by glutamine, glutamate, or sometimes by a lysine residue. In the latter case the lysine amino group would have to be unprotonated in order to act as an acceptor of the hydrogen bond from the exoamino group of adenine. Moreover, a monovalent cation cannot be involved in the positioning of the lysine side chain. Indeed, the structure of archaeal-type SAHase from Thermotoga maritima crystallized in the presence of the SAH substrate does not contain any metal cation in the substrate binding region12.
Potassium cations ensure the highest activity through the regulation of enzyme dynamics
The crystallographic studies of SAHases show that the enzymes can exist in at least two distinct conformations, i.e., in the open (ligand-free) and closed (ligand-bound) state. On the other hand, measurements of fluorescence anisotropy (conducted for enzymes with a covalently attached fluorescence probe) in solution revealed that the domain oscillations occur also in substrate-free SAHase24,28. These results indicated that the enzyme exists in an equilibrium of the open and closed states, shifted in the direction of the of the substrate-free open form. The frequency of the oscillations was estimated28 at ~4 × 107 s−1. This value exceeds by several orders of magnitude the diffusional-encounter frequency of the enzyme27, and by 4–8 orders of magnitude the catalytic rates (kcat) of SAHases from various sources29. Confrontation of these numbers could give the impression that the probability of binding of the substrate and its conversion to products, which ultimately need to be released, is very low. However, in structural studies, binding of the substrate induces the enzyme to change its conformational from the open to the closed state. It is essential that the enzyme should not be frozen in the closed state, but stayed in it only as long as is required for the catalytic reaction to complete, and then proceeded to the open conformation for product release and binding of another substrate molecule. At this point the exact role of the K+ ions in the enzymatic activity cannot be fully explained. The cation/ligand binding regions are not affected structurally by the type of the coordinated monovalent cation, but obviously there are significant cation-dependent differences in the thermodynamics of the ligand binding and enzyme kinetics.
To evaluate this puzzling effect of alkali cations on SAHase activity, two experiments were performed, using 2′-deoxyadenosine, an inhibitor that is involved in the irreversible reduction of the NAD+ cofactor to NADH during the chemical conversion of the inhibitor to adenine and a sugar residue5,6. In the first experiment, PaSAHase was incubated in the presence of 2′-deoxyadenosine in a buffer containing Rb+ or K+ ions. In the second experiment, the enzyme was first incubated with adenosine in the presence of Rb+ or K+ and subsequently 2′-deoxyadenosine was added. In both experiments, the rate of NADH formation was monitored spectrofluorimetrically (Fig. 5a,b). In the first experiment at its initial stage, the rate of NADH formation was only slightly higher for the reaction conducted in the presence of K+, however, the intensity of fluorescence emission reached a plateau faster in the presence Rb+ ions, indicating that in the time course the SAHaseclosed-Ligand-Rb+ complex forms more easily and/or the ligand is bound more tightly. In the second experiment, the rate of NADH formation was significantly lower in the presence of Rb+. Moreover, in the presence of Rb+ the fluorescence emission plateau was reached at lower intensity, indicating lower content of the reduced form of the cofactor. This result clearly indicates that the SAHaseclosed-Ligand-Rb+ complex is more stable than SAHaseclosed-Ligand-K+, as the exchange of the bound adenosine to 2′-deoxyadenosine is hampered in the complex containing the Rb+ ions.
The above experiments strongly suggest that for the explanation of the role of potassium in the catalytic activity of SAHase, one should consider the stability of the enzyme-ligand-cation complex (SAHaseclosed-Ligand-Me+). Assuming the same ligand (e.g., adenosine) is bound in the active site, the stability of such a complex would depend only on the metal cation. Coordination of the alkali ion by protein and water oxygen atoms can be treated as a hydration-like process, involving ion-dipole interactions. From the thermodynamic point of view, a decrease in the absolute value of the enthalpy of ion hydration is correlated with the increase of the ionic radius and indicates stronger ion-dipole interactions with smaller ions. However, this is not the case in the SAHaseclosed-Ligand-Me+ complex, where the coordination region is rigid with very similar, cation-independent conformation found in different SAHase models (Fig. 3b). The cation is involved in the formation of a network of polar contacts including the coordinating loop (residues T380-S384, part of the molecular hinge), the side chain of Q65, the substrate/ligand, and several water molecules (Fig. 3a). The ion coordination region is involved in ligand binding and seems to be ideally suited to coordinate K+ and Rb+, the two ions tested that have similar ionic radii (1.46 vs 1.56 Å, coordination number VII)30. This conclusion is confirmed by the ITC study, which revealed that binding of the adenosine ligand is very similar and most efficient in the presence of these two cations. On the other hand, their influence on enzyme activity is completely opposite. The ionic radius of Rb+ is slightly larger than K+ and, therefore, it should form a more stable SAHaseclosed-Ligand-Me+ complex, as the contribution of the coordination bond to the protein/water O–Rb+ interaction is higher than for the complex with K+. In consequence, dissociation of the SAHaseclosed-Ligand-Rb+ complex is more difficult and the enzyme is arrested in its closed state. In this scenario, the Rb+ ions inhibit the enzyme activity in a noncompetetive manner. In the SAHaseclosed-Ligand-K+ complex, the contribution of the coordination bond to metal binding is lower, resulting in a less stable complex. In the presence of K+ ions the complex stability seems to be ideally tuned, as the maximum catalytic activity of the enzyme is observed. The complex is stable enough to keep the enzyme in the closed state for the time required to complete the enzymatic reaction and, therefore, the catalytic cycle can be completed by changing the enzyme conformation from closed to open.
Ligand binding and enzymatic activity are impeded when other alkali cations are used. This could be explained by the lower stability of the SAHaseclosed-Ligand-Me+ complexes. Similar enzymatic activity and adenosine binding constants are observed in the presence of Na+ and Cs+ ions. The ionic radius of Cs+ (1.67 Å, coordination number VI) is larger than of other alkali ions and thus it should destabilize the complex. Another possible explanation is that Cs+, because of its size, does not fully occupy the available binding sites. The ionic radius of Na+ is significantly smaller (1.02 or 1.12 Å, coordination number VI or VII, respectively) than of K+. Therefore, the stability of the SAHaseclosed-Ligand-Na+ complex is lower, as the ionic contribution to Na+ coordination is higher than in complexes containing Rb+ or K+ ions. Additionally, numerous sodium-containing SAHase models indicate that the distance between the Na+ ion and the amide Oε atom of Q65 is too long and that this Na+–Q65 amide (which is still ordered) interaction should be considered as purely ionic; this would further reduce the stability of the complex. In consequence, complexes containing Cs+ or Na+ are not stable enough to support a high rate of the catalyzed reaction. Even lower (but comparable) activities are observed for the reactions carried out in the presence of Li+ (0.76 Å, coordination number VI) or in the absence of any alkali metal. Moreover, no heat effect was detected during the adenosine binding ITC experiment in in the presence of Li+. As proposed above, binding of the monovalent cation does not take place when the enzyme is in the open conformation, but occurs only after the conformational open-closed change that allows Q65 to approach the cation. Therefore, the possibility of the formation of an SAHaseclosed-Ligand-Li+ complex is questionable and the results may suggest that the Li+ ion is too small to be coordinated and, therefore, is unable to order the side chain of Q65.
Zn2+ is a potent inhibitor of PaSAHase
The Zn2+ cation was incorporated into recombinant PaSAHase during expression and co-purifies with the enzyme. It was identified in two crystal structures of the enzyme and its presence was additionally confirmed by X-ray fluorescence spectroscopy (Supplementary Information Fig. S2). It should be noted that this is the first report of a divalent cation identification in any SAHase structure. Co-purification of Zn2+ with PaSAHase indicates that the enzyme has a very high affinity for this cation. First of all, the recombinant protein was purified using affinity chromatography with Ni2+ ions, which are chemically very similar to Zn2+. However, no nickel ions were detected in the protein sample using XRF. Secondly, although the total intracellular Zn2+ concentration is in the millimolar range, it is as low as pico- to femtomolar for free zinc ions31,32,33,34. In E. coli cells the concentration of free zinc ions has been established as ~20 pM35. Our enzymatic assays revealed that recombinant PaSAHase has only residual activity. Efficient removal of the Zn2+ ions (and of any metal ions for that matter) using TPEN restored the enzymatic activity, which shows that the zinc ions inhibit the activity of PaSAHase. Specifically, our kinetics studies based on PaSAHase inactivation (Fig. 6a) revealed that a tightly bound Zn2+ cation acts as a very strong noncompetitive inhibitor with an inhibitory constant Ki as low as 15 nM. Furthermore, the enzymatic study indicated that Zn2+ locks the enzyme-ligand complex in the closed conformation. This assay was performed analogously to the tests for the stability of the SAHaseclosed-Ligand-Me+ complexes that utilized 2′-deoxyadenosine. In the Zn2+ case, PaSAHase was first incubated in the presence of K+ ions with adenosine and Zn2+ ions at various concentrations, and subsequently, 2′-deoxyadenosine was added. The rate of NADH formation was monitored spectrofluorimetrically (Fig. 6b). The highest rate was observed for the reaction without any addition of Zn2+ and gradually decreased with increasing Zn2+ concentration. These results clearly indicate that the Zn2+ ions arrest the enzyme in the closed conformation stymieing the exchange of adenosine to 2′-deoxyadenosine.
Our crystal structures help to elucidate this puzzling behavior by showing that there is a tetrahedral zinc binding site, formed by three highly conserved amino acid residues involving S (Cys85), N (His323), and two O (Asp139) ligand atoms, located in the active site, where - together with the H323-F324 molecular gate - the divalent cation shuts access to the active site of the enzyme. Moreover, the Zn2+ cation is located at the interface between the two principal domains and is coordinated by three ligands from the substrate-binding domain (C85 Sγ, D139 O and D139 Oδ1) and one ligand from the cofactor-binding domain (H323 Nε1), thus further stabilizing the SAHaseclosed-Ligand-K+ complex. The zinc binding sites are not fully occupied and, therefore, the side chain of H323 from the molecular gate is modeled in two states, differing in ~180° flip of the imidazole ring. In both conformations the molecular gate remains shut. The rotation of the H323 side chain in the Zn2+ complex is necessary for the formation of the coordination bond. The second rotamer interacts via the H323 Nδ1 atom with the O5′ atom of adenosine. The dual conformation of H323 is correlated with a similar disorder of the adenosine O5′ atom. The details of the zinc ion coordination are included in Fig. 1a,b and Supplementary Information (Table S5).
The mechanism of PaSAHase inactivation by zinc cations is different from that proposed for the inhibition of human placental SAHase activity by Cu2+ ions17. The latter study revealed that binding of copper cations affects protein-NAD+ interactions. In turn, the cofactor is released from the enzyme and the catalytic cycle cannot proceed anymore. The inhibition constants of zinc (~15 nM) and copper (~25 nM)17 ions are very low and similar. It was suggested that the copper-SAHase interactions may have biological significance, e.g., in the regulation of cellular methylation reactions or copper metabolism36,37,38,39,40. Contrary to that speculation, so far there is no literature evidences on any biological cross-talk between SAHase and zinc ions. However, since the total intracellular zinc concentration is in the range of millimolar, such an interaction with PaSAHase cannot be excluded.
PaSAHase-Zn2+ interactions were also tested by ITC experiments (Fig. 6c). Upon titration in the presence of K+ cations, the stoichiometry of protein:Zn2+ binding is around one zinc cation (0.90 ± 0.06) per one subunit with the apparent binding constant Kd of 12.7 ± 2.9 μM. The ITC results are in agreement with the crystallographic models of PaSAHase which also indicate the presence of only one Zn2+ site per subunit.
Monovalent cations are known to activate numerous enzymes but the mechanisms of their action could be different. Two types of activation have been proposed41. Activation is defined as type I for the enzymatic reactions where the cation interacts directly with a substrate to facilitate its binding (type Ia) or hydrolysis (type Ib). Frequently, a monovalent cation is utilized during the catalytic cycle in synergy with an additional divalent cation, e.g., Mg2+, Mn2+ or Zn2+ 42,43,44,45,46. A characteristic feature of enzymes activated by type I mechanism is a strong preference for a particular monovalent cation to ensure the highest catalytic activity43,47,48,49,50. This preference is usually related to a specific spatial arrangement of the active site or to the occurrence of optimal ionic interactions with a substrate provided by a particular monovalent cation41. On the other hand, the type of monovalent cation is not so strict for enzymes activated by type II mechanism. A striking feature of type II activation is that the monovalent cation does not interact with the substrate directly. The mechanism of type II activation is based on structural changes upon the monovalent cation binding, which could occur at various (e.g., local or/and global) level(s). Therefore, the detailed mechanism of this activation might be difficult to fully explain. For instance, binding of monovalent ion(s) could induce conformational changes within the whole subunit, the active site, or allosteric sites, and this in turn could facilitate substrate binding51,52,53,54,55,56,57,58. Additionally, other effects could also be observed, for instance, stabilization of the quaternary structure53, shifting of the equilibrium between the active and inactive conformers, or rigidifying of the enzyme structure and increasing protein thermal stability57,58,59.
S-adenosyl-l-homocysteine hydrolase obviously does not fall in the type I category as the monovalent cation does not interact with the ligand directly. It is true that the activity of PaSAHase depends on the cation type with a strong preference for K+, but the activation seems to be more similar to the situation defined for the type II mechanism. In SAHases, the monovalent cation participates in the ordering and proper orientation of Q65, the key residue involved in ligand binding. On the other hand, Q65 behaves similarly in the presence of different monovalent cations. Moreover, the conformation of the cation binding site in different SAHases is almost identical despite the presence of various monovalent cations, including NH4+, Na+, K+, or Rb+. Therefore, the strong preference of SAHases for K+ cannot be explained at the structural level alone. Our results strongly support the hypothesis that the role of the K+ ion is not restricted to fixing the orientation of the Q65 side chain. Instead, we propose that SAHases are activated by a special variant of type II mechanism, based on tuning of the enzyme dynamics (domain movement), which depends on the type of the coordinated cation. K+, but not other alkali cations, enables unique dynamic properties of the enzyme to ensure its maximum activity. The K+ ion stabilizes the enzyme-substrate complex in the closed conformation for a time interval required to complete the catalytic cycle. Stabilization of the closed state is achieved by (i) rigidifying the hinge region involved in substrate-induced domain reorientation and/or (ii) formation of additional polar contacts at the interface between the substrate- and cofactor-binding domains. The influence of metal cations on the enzyme dynamics can be exploited for enzyme inhibition. For example, the Rb+ cation is an inhibitor occupying the potassium site at the interdomain hinge. On the other hand, the potent inhibitory effect of Zn2+ is based on binding at the molecular gate and arresting the enzyme in the closed conformation.
Cloning, expression and purification of PaSAHase and Q65A mutein
The coding sequence of the ahcY gene was amplified by PCR from P. aeruginosa PAO1 genomic DNA. The amplicon was cloned into pMCSG57 expression vector using the ligation independent cloning reaction. The construct was used for Q65A mutant generation via PIPE60 cloning with the following primers: 5′-ATCGCGACCGGCGTGCTGATCGAGACCCTGGTC and 5′-GGTCGCGATGGTCATGTGGATGCAACCGAGGAT. The sequence of both constructs was confirmed by sequencing. The constructs carrying the coding sequence of the wild type PaSAHase or its Q65A mutant were transformed into BL21-CodonPlus(DE3)®-RIPL E. coli cells and expressed. 10 mL of LB medium containing 34 μg·mL−1 chloramphenicol and 100 μg·mL−1 ampicillin were inoculated and grown overnight at 310 K and the culture was used for inoculation of 1 L of LB medium, which was subsequently cultivated with appropriate antibiotics to an OD600 of 0.8. The temperature was decreased to 291 K and protein expression was induced with IPTG at a final concentration of 0.35 mM. The cells were harvested 20 hours after induction and flash-frozen in liquid nitrogen.
The purification procedure was the same for the wild type enzyme and Q65A mutein. The cell pellet was resuspended in buffer A (20 mM imidazole, 500 mM NaCl, 20 mM Tris·HCl pH 8.0, 10% glycerol) with the addition of 1 mM TCEP·HCl (to enhance enzyme stability) and 100 μg·mL−1 lysozyme. Cells were disrupted by sonication on ice and centrifuged for removal of debris. The supernatant was loaded onto a HisTrap column equilibrated with 0.05 M NiSO4. The protein was eluted with a buffer containing 300 mM imidazole, 500 mM NaCl, 20 mM Tris·HCl pH 8.0, 10% glycerol, and 1 mM TCEP·HCl. TEV protease was added at the final concentration of 0.1 mg·mL−1 and the protein solution was extensively dialyzed against buffer A. After overnight incubation at 277 K, the solution was loaded onto a HisTrap column equilibrated with 0.05 M NiSO4 and the protein was eluted with buffer A, subsequently exchanged for buffer B (100 mM KCl, 25 mM Tris·HCl pH 8.0, 1 mM TCEP·HCl) via dialysis. Next, a modified procedure of Yuan et al.20 was used for the preparation of the apo form of the enzyme. Briefly, a solution containing 5 mg of recombinant PaSAHase dissolved in 5 mL of buffer B was gradually mixed with 10 mL of saturated solution of (NH4)2SO4 at pH 3.3, and then stored for 10 min on ice. The mixture was centrifuged and the precipitate was dissolved in 5 mL of buffer C (100 mM KCl, 25 mM Tris·HCl pH 8.0). The enzyme was precipitated again as above and the pellet was washed with saturated neutral solution of (NH4)2SO4. Finally, the precipitated apo PaSAHase was dissolved in 2 mL of buffer C and subsequently NAD+ was added to a final concentration of 2 mM. After 30 minutes of incubation on ice, the mixture was loaded onto a Superdex 200 (Pharmacia) gel filtration column pre-equilibrated with buffer D (100 mM KCl, 25 mM HEPES·KOH pH 7.5, 1 mM TCEP·HCl). The protein was eluted with buffer D as a tetramer. Fractions with PaSAHase were concentrated to 20 mg·mL−1 by ultracentrifugation and the fresh protein solution was used for initial activity study, X-ray fluorescence experiments, and crystallization of Zn2+-containing PaSAHase complexes. For other studies, the purification procedure was modified by introduction of an additional step required to efficiently remove the Zn2+ ions by a strong chelator. Briefly, the gel filtration step was preceded with an extensive dialysis of the sample in buffer C supplemented with 50 μM N,N,N′,N′-tetrakis(2-pyridinylmethyl)−1,2-ethanediamine (TPEN). The subsequent purification steps were unchanged.
Both purified proteins are extended at the N-terminus by a short tripeptide (SNA-) cloning artifact. SDS-PAGE analysis confirmed the size of the expressed proteins (~53 kDa). Finally, mass spectrometry was used to confirm the size and sequence of the wild type enzyme.
Assays for SAHase activity and inhibition
Assays for PaSAHase activity in the hydrolytic direction were carried out spectrophotometrically and the rate of L-homocysteine (Hcy) formation was measured by monitoring its reaction with 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB)21. Assays were performed in 3 mL volume in a buffer containing 100 mM MeCl (where Me+ corresponds to Li+, Na+, K+, Rb+, or Cs+ ion) and 25 mM HEPES·MeOH pH 7.5, or a buffer containing 100 mM Tris·HCl pH 7.5. For the Q65A mutein, the experiments were conducted in a buffer containing 100 mM KCl and 25 mM HEPES·KOH pH 7.5. The buffers were supplemented with six units of adenosine deaminase, 100 μM DTNB, and 0.32 μM of PaSAHase or its mutein. The reaction was initiated by the addition of S-adenosyl-l-homocysteine (SAH) at a final concentration from 2.5 to 200 μM. The conversion of Hcy to Hcy-TNB was carried out at 293 K. The reaction progress was measured for one minute and monitored at 412 nm using a U-3900H spectrophotometer (Hitachi). Initial velocity parameters were estimated from the linear region of the recorded curve.
For the inhibition study, PaSAHase (0.35 μM) in a buffer containing 100 mM KCl and 25 mM Tris·HCl pH 7.5 was incubated with Zn2+ at different concentrations, ranging from 0.165 to 20 μM. The reaction was initiated by the addition of SAH at a final concentration of 85 μM. The enzymatic activity was followed in the hydrolytic direction by monitoring homocysteine formation via its reaction with DNTB to determine the IC50 constant. For the sample without the addition of Zn2+ ions, 100% activity was assigned. All measurements were performed in duplicates. The experimental data were analyzed with the GraFit 7.0 software (Erithacus) to obtain the kinetic parameters of the enzymatic reactions: substrate affinity (KM), activity (Vmax), as well as catalytic rate (kcat) or IC50 value for inhibition. The IC50-to-Ki converter61 was applied to calculate the inhibition constant (Ki) for Zn2+ ions using the noncompetitive model of inhibition.
Isothermal titration calorimetry
ITC measurements were performed at 293 K using a MicroCal iTC200 calorimeter (GE Healthcare). For the adenosine binding studies, the wild type protein was dialyzed against a buffer containing 100 mM MeCl and 25 mM HEPES·MeOH pH 7.5, or an alkali-cation-free buffer containing 100 mM Tris·HCl pH 7.5. The experiment for the Q65A mutein was conducted in a buffer containing 100 mM KCl and 25 mM HEPES·KOH pH 7.5. The final protein concentrations were in the range of 100–120 µM. Adenosine was dissolved in the dialysis buffers to the concentrations of 0.6 to 1.0 mM. The K+ ion binding study was conducted in 50 mM Tris·HCl pH 7.5 at PaSAHase concentration of 70 μM. The protein was titrated with 1 mM KCl in 50 mM Tris·HCl pH 7.5. The Zn2+ ion binding study was conducted in a buffer containing 100 mM KCl and 50 mM Tris·HCl pH 7.5 at PaSAHase concentration of 45 μM. The protein was titrated with 2 mM ZnCl2. In all ITC experiments the ligand was injected to the protein solution (300 μL) in 2 µL aliquots until saturation was observed. The protein concentrations were estimated by the Bradford method and are presented for a single PaSAHase subunit. The raw ITC data were analyzed with the ORIGIN 7.0 software (OriginLab) to obtain the thermodynamic parameters of the complexation reactions: stoichiometry (N), dissociation constant (Kd), as well as changes in enthalpy (ΔH) and entropy (ΔS). For sigmoidal titration curves, the one set of sites model was fitted and N was obtained from the experiment. For hyperbolic curves, for which the determination of N is impossible, N was fixed while fitting the same model. All measurements were performed in duplicates.
Time course of PaSAHase inactivation by 2′-deoxyadenosine
The measurements were performed at 293 K using an F-7000 spectrofluorotometer (Hitachi) in the volume of 1 mL. Irreversible formation of the reduced form of the cofactor (NADH) was monitored spectrofluorometrically by excitation at 340 nm and measurement of emission at 460 nm, as described previously20. The influence of K+ and Rb+ ions on the time-dependent inactivation of the enzyme was carried out for 15 μM PaSAHase in a buffer containing 100 mM KCl or RbCl, 25 mM HEPES·KOH or HEPES·RbOH pH 7.5, and 1 mM TCEP·HCl. In the first experiment, the reaction was initiated by the addition of 2′-deoxyadenosine to the final concentration of 5 mM. In the second experiment, the enzyme was incubated for 2 hours with 100 μM adenosine and subsequently 2′-deoxyadenosine was added at a final concentration of 200 μM. After one minute the reaction was monitored for 4000 seconds (first experiment) or until the intensity of fluorescence emission reached a plateau (second experiment). An analogous experiment was carried out to analyze the influence of Zn2+ cations on the enzyme. Herein, 15 μM PaSAHase in a buffer containing 100 mM KCl and 25 mM HEPES·KOH was incubated for 2 hours with adenosine (200 μM) and ZnCl2 (1, 5 or 10 μM) or without the divalent cation. The cofactor conversion reaction was initiated by the addition of 2′-deoxyadenosine to the final concentration of 5 mM and after one minute was monitored for 5000 seconds.
X-ray fluorescence spectroscopy
Freshly purified PaSAHase in buffer C from the batch not treated with Zn2+ chelator was suspended in a cryoloop with the diameter of 1.0 mm and vitrified in liquid nitrogen prior to X-ray fluorescence detection. Initial X-ray fluorescence spectrum for the energy range from 8000 to 11500 eV was recorded at BESSY beamline 14.1 using Amptek X-123 SDD X-ray spectrometer. Maximum of emission related to the presence of zinc ions was observed in the energy range from 9600–9700 eV (Supplementary Fig. 2).
23Na NMR Spectroscopy
23Na NMR spectra were measured on a BRUKER Avance 500 MHz spectrometer (5 mm BBFO BB-19F/1H Z-gradient probe). Six samples were prepared in 50 mM Tris·HCl pH 7.5, which contained: (1) 5 mM NaCl, (2) 5 mM NaCl + 1 mM Ado, (3) 5 mM NaCl + 0.3 mM PaSAHase, (4) 0.3 mM PaSAHase + 5 mM NaCl + 1 mM Ado, (5) 0.3 mM PaSAHase + 0.6 mM NaCl + 1 mM Ado, (6) 0.3 mM PaSAHase + 0.3 mM NaCl + 1 mM Ado. 23Na NMR chemical shifts are given in ppm relative to 5 mM NaCl in 50 mM Tris·HCl pH 7.5.
Crystallization and X-ray data collection
Protein solution in a buffer containing 100 mM KCl or RbCl, 25 mM HEPES·KOH or HEPES·RbOH pH 7.5, and 1 mM TCEP·HCl was incubated overnight with 2 mM of adenosine (Ado/K+/Zn2+), 2′-deoxyadenosine (2′-dAdo/K+/Zn2+ or 2′-dAdo/Rb+), or 3′-deoxyadenosine (3′-dAdo/K+) at 277 K. Crystallization drops were mixed from 2 μL of the protein solution (10 mg∙mL-1 measured spectrofotometrically at 280 nm) and 2 μL of the reservoir solution containing 20% (w/v) PEG8000 and 50 mM KH2PO4 (Ado/K+/Zn2+ and 2′-dAdo/K+/Zn2+), or 20% (w/v) PEG8000 and 50 mM RbH2PO4 (2′-dAdo/Rb+), or 15% (w/v) PEG8000, 50 mM KH2PO4 and 20% (v/v) glycerol (3′-dAdo/K+). Diffraction-quality crystals were grown within a few days at 292 K using the hanging-drop vapor-diffusion method. X-Ray diffraction data were measured at BESSY beamlines 14.1, 14.2, 14.3 or APS beamline SER-CAT 22-ID. Crystals of the 3′-dAdo/K+ complex were fished out directly from mother liquor and vitrified in liquid nitrogen. Other crystals were soaked for a few seconds in the reservoir solution supplemented with 20% (v/v) glycerol and vitrified in liquid nitrogen prior to X-ray data collection. The diffraction data extend to 1.35 Å (3′-dAdo/K+), 1.45 Å (2′-dAdo/Rb+), 1.60 Å (Ado/K+/Zn2+), or 1.75 Å (2′-dAdo/K+/Zn2+) resolution. Indexing and integration of the diffraction images was performed in the HKL3000 package62 (2′-dAdo/K+/Zn2+ and 3′-dAdo/K+) or XDSAPP graphical interface63 of the XDS package64 (Ado/K+/Zn2+ and 2′-dAdo/Rb+). The intensity data were scaled in HKL3000 or XDS. The final data sets are characterized in Supplementary Table S1.
Structure solution, refinement and validation
The crystal structure of PaSAHase in the 3′-dAdo/K+ complex was solved by molecular replacement, as implemented in the program PHASER65 from the CCP4 suite66 using a subunit of H. sapiens SAHase27 as the search model (PDB entry 1LI4, chain A). The correct solution was found in space group C2 with two subunits in the asymmetric unit, from which crystallographic symmetry generates the complete PaSAHase homotetramer. The other three crystal structures were solved by molecular replacement using PHASER and a subunit from the 3′-dAdo/K+ solution as a search probe. The correct solutions were found in space group C2 with four subunits in the asymmetric unit forming the PaSAHase tetramer. For all four complexes, automatic model building was carried out with the online version of ARP/wARP67. Anisotropic (3′-dAdo/K+, 2′-dAdo/Rb+) or isotropic (Ado/K+/Zn2+, 2′-dAdo/K+/Zn2+) stereochemically-restrained structure-factor refinement was carried out in REFMAC568 with maximum-likelihood targets and with the inclusion of three TLS groups69 (Ado/K+/Zn2+ and 2′-dAdo/K+/Zn2+) per protein chain, as suggested by the TLSMD server70. The ligands were identified without ambiguity in mFo-DFc omit electron density maps phased with the contribution of the protein atoms only. The occupancy of the zinc ions was adjusted manually to satisfy simultaneously two conditions: (i) clean difference maps and (ii) ADP parameters of the zinc ions similar to those of the adjacent atoms. The alkali cation binding sites were confirmed with CheckMyMetal71. Additionally, the Rb+ ions were clearly present in anomalous difference Fourier maps. The COOT program72 was used for manual modeling in electron density maps. Stereochemical quality of the models was assessed using the wwPDB validation pipeline73. Final refinement statistics for all four crystal structures are reported in Supplementary Table 1.
Other software used
Atomic coordinates and ADP parameters, as well as structure factors have been deposited in the Protein Data Bank (PDB) with the accession codes 6F3M (Ado/K+/Zn2+), 6F3O (2′-dAdo/K+/Zn2+), 6F3P (3′-dAdo/K+), and 6F3Q (2′-dAdo/Rb+). Raw diffraction images were deposited in the Integrated Resource for Reproducibility in Macromolecular Crystallography (ProteinDiffraction.org) with the following DOIs: https://doi.org/10.18430/M36F3M (Ado/K+/Zn2+), https://doi.org/10.18430/M36F3O (2’-dAdo/K+/Zn2+), https://doi.org/10.18430/M36F3P (3’-dAdo/K+) and https://doi.org/10.18430/M36F3Q (2’-dAdo/Rb+).
Richards, H. H., Chiang, P. K. & Cantoni, G. L. Adenosylhomocysteine hydrolase. Crystallization of the purified enzyme and its properties. J Biol Chem 253, 4476–4480 (1978).
Poulton, J. E. & Butt, V. S. Purification and properties of S-adenosyl-l-methionine: caffeic acid O-methyltransferase from leaves of spinach beet (Beta vulgaris L.). Biochim Biophys Acta 403, 301–314 (1975).
Chiang, P. K. & Cantoni, G. L. Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. Biochem Pharmacol 28, 1897–1902 (1979).
Chiang, P. K. Biological effects of inhibitors of S-Adenosylhomocysteine hydrolase. Pharmacol Ther 77, 115–134 (1998).
Hershfield, M. S. Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine. J Biol Chem 254, 22–25 (1979).
Brzezinski, K., Dauter, Z. & Jaskolski, M. High-resolution structures of complexes of plant S-adenosyl-l-homocysteine hydrolase (Lupinus luteus). Acta Crystallogr D Biol Crystallogr 68, 218–231 (2012).
Turner, M. A. et al. Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat Struct Biol 5, 369–376 (1998).
Hu, Y. et al. Crystal structure of S-adenosylhomocysteine hydrolase from rat liver. Biochemistry 38, 8323–8333 (1999).
Tanaka, N. et al. Crystal structure of S-adenosyl-l-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum. J Mol Biol 343, 1007–1017 (2004).
Reddy, M. C. M. et al. Crystal structures of Mycobacterium tuberculosis S-adenosyl-l-homocysteine hydrolase in ternary complex with substrate and inhibitors. Protein Sci 17, 2134–2144 (2008).
Manszewski, T., Singh, K., Imiolczyk, B. & Jaskolski, M. An enzyme captured in two conformational states: crystal structure of S -adenosyl- L -homocysteine hydrolase from Bradyrhizobium elkanii. Acta Crystallogr D Biol Crystallogr 71, 2422–2432 (2015).
Zheng, Y. et al. Crystal structures of S-adenosylhomocysteine hydrolase from the thermophilic bacterium Thermotoga maritima. J Struct Biol 190, 135–142 (2015).
Brzezinski, K. et al. S-adenosyl-l-homocysteine hydrolase from a hyperthermophile (Thermotoga maritima) is expressed in Escherichia coli in inactive form - Biochemical and structural studies. Int J Biol Macromol 104, 584–596 (2017).
Kusakabe, Y. et al. Structural insights into the reaction mechanism of S-adenosyl-l-homocysteine hydrolase. Sci Rep 5, 16641 (2015).
Czyrko, J., Jaskolski, M. & Brzezinski, K. Crystal Structure of S-adenosyl-l-homocysteine hydrolase from Cytophaga hutchinsonii, a case of combination of crystallographic and noncrystallographic symmetry. Croat Chem Acta 91 (2018).
Palmer, J. L. & Abeles, R. H. The mechanism of action of S-adenosylhomocysteinase. J Biol Chem 254, 1217–1226 (1979).
Li, M. et al. Copper ions inhibit S-adenosylhomocysteine hydrolase by causing dissociation of NAD+ cofactor. Biochemistry 46, 11451–11458 (2007).
Komoto, J. et al. Effects of site-directed mutagenesis on structure and function of recombinant rat liver S-adenosylhomocysteine hydrolase. Crystal structure of D244E mutant enzyme. J Biol Chem 275, 32147–32156 (2000).
Manszewski, T., Szpotkowski, K. & Jaskolski, M. Crystallographic and SAXS studies of S-adenosyl-l-homocysteine hydrolase from Bradyrhizobium elkanii. IUCrJ 4, 271–282 (2017).
Yuan, C. S., Yeh, J., Liu, S. & Borchardt, R. T. Mechanism of inactivation of S-adenosylhomocysteine hydrolase by (Z)−4′,5′-didehydro-5′-deoxy-5′-fluoroadenosine. J Biol Chem 268, 17030–17037 (1993).
Yuan, C. S., Ault-Riché, D. B. & Borchardt, R. T. Chemical modification and site-directed mutagenesis of cysteine residues in human placental S-adenosylhomocysteine hydrolase. J Biol Chem 271, 28009–28016 (1996).
Lozada-Ramírez, J. D., Martínez-Martínez, I., Sánchez-Ferrer, A. & García-Carmona, F. A colorimetric assay for S-adenosylhomocysteine hydrolase. J Biochem Biophys Meth 67, 131–140 (2006).
Turner, M. A. et al. Structure and function of S-adenosylhomocysteine hydrolase. Cell Biochem Biophys 33, 101–125 (2000).
Wang, M. et al. Effects of Ligand Binding and Oxidation on Hinge-Bending Motions in S-adenosyl-l-homocysteine Hydrolase. Biochemistry 45, 7778–7786 (2006).
Clausen, M. J. V. & Poulsen, H. Sodium/Potassium Homeostasis in the Cell. Met Ions Life Sci 12, 41–67 (2013).
Stepkowski, T., Brzeziński, K., Legocki, A. B., Jaskólski, M. & Béna, G. Bayesian phylogenetic analysis reveals two-domain topology of S-adenosylhomocysteine hydrolase protein sequences. Mol Phylogenet Evol 34, 15–28 (2005).
Yang, X. et al. Catalytic strategy of S-adenosyl-l-homocysteine hydrolase: transition-state stabilization and the avoidance of abortive reactions. Biochemistry 42, 1900–1909 (2003).
Yin, D. et al. Substrate binding stabilizes S-adenosylhomocysteine hydrolase in a closed conformation. Biochemistry 39, 9811–9818 (2000).
Schomburg, I. et al. The BRENDA enzyme information system–From a database to an expert system. J. Biotechnol. 261, 194–206 (2017).
Shannon, R. D. Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr Sect A 32, 751–767 (1976).
Outten, C. E. Femtomolar Sensitivity of Metalloregulatory Proteins Controlling Zinc Homeostasis. Science 292, 2488–2492 (2001).
Jacobsen, F. E., Kazmierczak, K. M., Lisher, J. P., Winkler, M. E. & Giedroc, D. P. Interplay between manganese and zinc homeostasis in the human pathogen Streptococcus pneumoniae. Met Integr Biometal Sci 3, 38–41 (2011).
Begg, S. L. et al. Dysregulation of transition metal ion homeostasis is the molecular basis for cadmium toxicity in Streptococcus pneumoniae. Nat Commun 6 (2015).
Capdevila, D. A., Wang, J. & Giedroc, D. P. Bacterial Strategies to Maintain Zinc Metallostasis at the Host-Pathogen Interface. J Biol Chem 291, 20858–20868 (2016).
Patzer, S. I. & Hantke, K. The ZnuABC high-affinity zinc uptake system and its regulator Zur in Escherichia coli. Mol Microbiol 28, 1199–1210 (1998).
Bethin, K. E., Petrovic, N. & Ettinger, M. J. Identification of a major hepatic copper binding protein as S-adenosylhomocysteine hydrolase. J Biol Chem 270, 20698–20702 (1995).
McArdle, H. J., Bingham, M. J., Summer, K. & Ong, T. J. Cu metabolism in the liver. Adv Exp Med Biol 448, 29–37 (1999).
Mansoor, M. A. et al. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 46, 385–391 (2000).
Chen, J. & Liu, Q. Copper ion’ inhibition on activity of S-Adenosylhomocysteine hydrolase. Chin Sci Bull 47, 421–424 (2002).
Li, Y., Chen, J., Liu, J., Yang, X. & Wang, K. Binding of Cu2+ to S-adenosyl-l-homocysteine hydrolase. J Inorg Biochem 98, 977–983 (2004).
Gohara, D. W. & Di Cera, E. Molecular Mechanisms of Enzyme Activation by Monovalent Cations. J Biol Chem 291, 20840–20848 (2016).
Larsen, T. M., Laughlin, L. T., Holden, H. M., Rayment, I. & Reed, G. H. Structure of rabbit muscle pyruvate kinase complexed with Mn2+, K+, and pyruvate. Biochemistry 33, 6301–6309 (1994).
Viitanen, P. V. et al. Chaperonin-facilitated refolding of ribulosebisphosphate carboxylase and ATP hydrolysis by chaperonin 60 (groEL) are K+ dependent. Biochemistry 29, 5665–5671 (1990).
Villeret, V., Huang, S., Fromm, H. J. & Lipscomb, W. N. Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase. Proc Natl Acad Sci USA 92, 8916–8920 (1995).
Komoto, J., Yamada, T., Takata, Y., Markham, G. D. & Takusagawa, F. Crystal structure of the S-adenosylmethionine synthetase ternary complex: a novel catalytic mechanism of S-adenosylmethionine synthesis from ATP and Met. Biochemistry 43, 1821–1831 (2004).
Wu, Y., He, Y., Moya, I. A., Qian, X. & Luo, Y. Crystal structure of archaeal recombinase RADA: a snapshot of its extended conformation. Mol Cell 15, 423–435 (2004).
Toraya, T., Sugimoto, Y., Tamao, Y., Shimizu, S. & Fukui, S. Propanediol dehydratase system. Role of monovalent cations in binding of vitamin B12 coenzyme or its analogs to apoenzyme. Biochemistry 10, 3475–3484 (1971).
Wheatley, R. W., Juers, D. H., Lev, B. B., Huber, R. E. & Noskov, S. Y. Elucidating factors important for monovalent cation selectivity in enzymes: E. coli β-galactosidase as a model. Phys Chem Chem Phys 17, 10899–10909 (2015).
Marcus, F. & Hosey, M. M. Purification and properties of liver fructose 1,6-bisphosphatase from C57BL/KsJ normal and diabetic mice. J Biol Chem 255, 2481–2486 (1980).
Wu, Y., Qian, X., He, Y., Moya, I. A. & Luo, Y. Crystal structure of an ATPase-active form of Rad51 homolog from Methanococcus voltae. Insights into potassium dependence. J Biol Chem 280, 722–728 (2005).
Paul, R., Patra, M. D. & Sen, U. Crystal structure of apo and ligand bound Vibrio cholerae ribokinase (Vc-RK): role of monovalent cation induced activation and structural flexibility in sugar phosphorylation. Adv Exp Med Biol 842, 293–307 (2015).
Hohenester, E., Keller, J. W. & Jansonius, J. N. An alkali metal ion size-dependent switch in the active site structure of dialkylglycine decarboxylase. Biochemistry 33, 13561–13570 (1994).
AEvarsson, A. et al. Crystal structure of human branched-chain alpha-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease. Structure 8, 277–291 (2000).
Woehl, E. U. & Dunn, M. F. Monovalent metal ions play an essential role in catalysis and intersubunit communication in the tryptophan synthase bienzyme complex. Biochemistry 34, 9466–9476 (1995).
Peracchi, A., Mozzarelli, A. & Rossi, G. L. Monovalent cations affect dynamic and functional properties of the tryptophan synthase alpha 2 beta 2 complex. Biochemistry 34, 9459–9465 (1995).
Dunn, M. F. Allosteric regulation of substrate channeling and catalysis in the tryptophan synthase bienzyme complex. Arch Biochem Biophys 519, 154–166 (2012).
Vogt, A. D., Bah, A. & Di Cera, E. Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa. J Phys Chem B 114, 16125–16130 (2010).
Vogt, A. D., Chakraborty, P. & Di Cera, E. Kinetic dissection of the pre-existing conformational equilibrium in the trypsin fold. J Biol Chem 290, 22435–22445 (2015).
Lechtenberg, B. C., Johnson, D. J. D., Freund, S. M. V. & Huntington, J. A. NMR resonance assignments of thrombin reveal the conformational and dynamic effects of ligation. Proc Nat. Acad Sci USA 107, 14087–14092 (2010).
Klock, H. E., Koesema, E. J., Knuth, M. W. & Lesley, S. A. Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins 71, 982–994 (2008).
Cer, R. Z., Mudunuri, U., Stephens, R. & Lebeda, F. J. IC 50 -to-K i: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Res 37, W441–W445 (2009).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307–326.
Sparta, K. M., Krug, M., Heinemann, U., Mueller, U. & Weiss, M. S. XDSAPP2.0. J Appl Crystallogr 49, 1085–1092 (2016).
Kabsch, W. XDS. Acta Crystallogr D Biol Crystallogr 66, 125–132 (2010).
McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658–674 (2007).
Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235–242 (2011).
Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc 3, 1171–1179 (2008).
Murshudov, G. N. et al. REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 67, 355–367 (2011).
Winn, M. D., Isupov, M. N. & Murshudov, G. N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57, 122–133 (2001).
Painter, J. & Merritt, E. A. TLSMD web server for the generation of multi-group TLS models. J Appl Crystallogr 39, 109–111 (2006).
Zheng, H. et al. CheckMyMetal: a macromolecular metal-binding validation tool. Acta Crystallogr D Struct Biol 73, 223–233 (2017).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 486–501 (2010).
Berman, H., Henrick, K. & Nakamura, H. Announcing the worldwide Protein Data Bank. Nat Struct Biol 10, 980–980 (2003).
Krissinel, E. & Henrick, K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60, 2256–2268 (2004).
Schrödinger, LLC. The PyMOL Molecular Graphics System. Version 1.8. (2015).
Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 539 (2011).
Work supported in part by an OPUS grant No. 2013/09/B/NZ1/01880 from the Polish National Science Center. The BioNanoTechno Center at the Institute of Chemistry, University of Bialystok was founded by the European Funds for Regional Development and the National Funds of the Ministry of Science and Higher Education, as part of the Operational Programme Development of Eastern Poland 2007–2013, project POPW.01.03.00-20-034/09-00. The research leading to these results received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under BioStruct-X (grant agreement N 283570). We thank HZB for the allocation of synchrotron radiation beamtime.
The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Czyrko, J., Sliwiak, J., Imiolczyk, B. et al. Metal-cation regulation of enzyme dynamics is a key factor influencing the activity of S-adenosyl-l-homocysteine hydrolase from Pseudomonas aeruginosa. Sci Rep 8, 11334 (2018). https://doi.org/10.1038/s41598-018-29535-y